ICYMI: Lamzede Now FDA-Approved for Alpha-Mannosidosis
Prior to February 2023, there were no FDA-approved treatment options for non-central nervous system manifestations of alpha-mannosidosis. But in mid-February 2023, Chiesi Global Rare Diseases shared via news release…